EMA Panel Backs Lusutrombopag for Adults With Liver Disease EMA Panel Backs Lusutrombopag for Adults With Liver Disease

The thrombopoietin receptor agonist is for severe thrombocytopenia in adults with chronic liver disease who are scheduled to undergo an invasive procedure.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news